Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
16 July 2014Website:
http://www.iradimed.comNext earnings report:
07 February 2025Last dividends:
20 August 2024Next dividends:
15 November 2024Price
after hours | Fri, 01 Nov 2024 20:00:01 GMTAnalysts recommendations
Institutional Ownership
IRMD Latest News
IRADIMED CORPORATION. (NASDAQ:IRMD ) Q3 2024 Earnings Conference Call October 31, 2024 11:00 AM ET Company Participants Roger Susi - President and Chief Executive Officer Jack Glenn - CFO Conference Call Participants Frank Takkinen - Lake Street Capital Markets Jason Wittes - ROTH Capital Partners Operator Welcome to the IRadimed Corporation Third Quarter of 2024 Financial Results Conference Call.
IRadimed (IRMD) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.43 per share a year ago.
WINTER SPRINGS, Fla., Oct. 03, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices, announced today that it will participate in the 3rd Annual ROTH Healthcare Opportunities Conference.
WINTER SPRINGS, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices, announced today that the Company will be participating in the Lake Street 8 th Annual Best Ideas Growth "Big 8" Conference.
IRADIMED CORPORATION (NASDAQ:IRMD ) Q2 2024 Results Conference Call August 1, 2024 12:00 PM ET Company Participants Roger Susi - President and Chief Executive Officer Matt Garner - Controller Conference Call Participants Frank Takkinen - Lake Street Capital Jason Wittes - ROTH Capital Partners Operator Welcome to the IRadimed Corporation Second Quarter of 2024 Financial Results Conference Call. [Operator Instructions] As a reminder, this call is being recorded today, August 1, 2024, and contains time-sensitive accurate information only today.
WINTER SPRINGS, Fla., Aug. 01, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) announced today its financial results for the three and six months ended June 30, 2024. The Company is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system, and non-magnetic patient vital signs monitoring systems that are designed for use during MRI procedures.
Winter Springs, Fla., July 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 second quarter financial results before the market opens on Thursday, August 1, 2024. Iradimed management will host a conference call the same day beginning at 12:00 p.m. Eastern Time to discuss those results and to answer questions.
IRADIMED CORPORATION (NASDAQ:IRMD) will be hosting its Q1 2024 Results Conference Call on May 2, 2024 at 11:00 AM ET. Presenting will be Roger Susi, President and CEO, and Jack Glenn, CFO. Joining the call are analysts Jason Wittes from ROTH Capital Partners and Frank Takkinen from Lake Street Capital. The operator will begin the call with a welcome message, followed by a question-and-answer session at the end.
IRadimed Corporation (IRMD) Q4 2023 Earnings Call Transcript
WINTER SPRINGS, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 fourth quarter financial results before the market opens on Thursday, February 8, 2024. Iradimed management will host a conference call the same day beginning at 9:00 a.m. Eastern Time to discuss those results and to answer questions.
What type of business is IRadimed?
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
What sector is IRadimed in?
IRadimed is in the Healthcare sector
What industry is IRadimed in?
IRadimed is in the Medical Devices industry
What country is IRadimed from?
IRadimed is headquartered in United States
When did IRadimed go public?
IRadimed initial public offering (IPO) was on 16 July 2014
What is IRadimed website?
https://www.iradimed.com
Is IRadimed in the S&P 500?
No, IRadimed is not included in the S&P 500 index
Is IRadimed in the NASDAQ 100?
No, IRadimed is not included in the NASDAQ 100 index
Is IRadimed in the Dow Jones?
No, IRadimed is not included in the Dow Jones index
When was IRadimed the previous earnings report?
No data
When does IRadimed earnings report?
The next expected earnings date for IRadimed is 07 February 2025